No More Finger Pricks – Know Labs Is Developing A Completely Non-Invasive Blood Glucose Monitor

Ron Erickson, Chairman and CEO of Know Labs, Inc (NYSEAMERICAN: KNW) was recently a guest on Benzinga’s All-Access.

Know Labs is a medical technology company that develops non-invasive medical diagnostics. Its proprietary technology platform, Bio-RFID, uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures which can be converted into physiologically meaningful information and insights. 

While the technology platform can measure a range of different analytes both inside and outside the body, the company is focused on the non-invasive measurement of blood glucose. It reports that there are over 1.5 billion people around the world living with diabetes and pre-diabetes. Currently, there are no medical-grade commercially available, truly non-invasive means of measuring blood glucose levels.

Watch the full interview here:

Featured photo by National Cancer Institute on Unsplash.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.